Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Mia J. Sullivan"'
Publikováno v:
Current Hematologic Malignancy Reports. 17:105-112
Publikováno v:
Current hematologic malignancy reportsPapers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance. 17(5)
This review describes ANKRD26-related thrombocytopenia (RT) from a molecular, clinical, and laboratory perspective, with a focus on the clinical decision-making that takes place in the diagnosis and management of families with ANKRD26-RT.ANKRD26-rela
Autor:
Juliana Perez Botero, Mia J. Sullivan
Publikováno v:
Annals of Blood. 6:37-37
Autor:
Mia J. Sullivan, Judy Larison, Ashley S. Roman, Lee Ann Weitekamp, Cindy S. Raven, Brian R. Curtis
Publikováno v:
Transfusion. 56:101-106
BACKGROUND Human neutrophil antigen (HNA)−4a/4bw is encoded by 230G>A in ITGAM, which results in an Arg61His substitution of the αM chain (CD11b) of complement receptor 3 (CR3; CD11b/18 or Mac-1). HNA-4a antibodies have been detected in the sera o
Publikováno v:
Transfusion. 57(7)
Autor:
Janice G. McFarland, Demin Wang, Namrata Peswani, Brian R. Curtis, Daniel W. Bougie, Anand Padmanabhan, Mia J. Sullivan, Daniel Eastwood, Curtis G. Jones, Richard H. Aster
Background Almost without exception, patients with heparin-induced thrombocytopenia/thrombosis (HIT) have antibodies that recognize platelet factor 4 (PF4) in a complex with heparin; however, many heparin-treated patients without HIT are also antibod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edaf0bb840834f657a0c20c28952f6e4
https://europepmc.org/articles/PMC5028397/
https://europepmc.org/articles/PMC5028397/
Publikováno v:
Transfusion. 52:2368-2374
BACKGROUND: People with the human neutrophil antigen (HNA)-3b/3b type can make HNA-3a antibodies, which have been reported to cause immune neutropenia disorders and are especially prone to cause severe cases of transfusion-related acute lung injury.
Publikováno v:
Transfusion. 57:1847-1848
Autor:
Mia J. Sullivan, Brian R. Curtis, Julie A. Peterson, Richard H. Aster, Adam Kanack, Daniel W. Bougie
Publikováno v:
Transfusion. 52:1112-1116
Antibodies specific for the leukocyte antigen HNA-3a are prone to cause severe, often fatal, transfusion-related acute lung injury (TRALI)1,2 when transfused with blood products.3–5 Unfortunately, it has not been practical to test blood donors rout
Autor:
Mia J. Sullivan, Richard H. Aster, Brian R. Curtis, Daniel W. Bougie, M. Trudy Holyst, Aniko Szabo
Publikováno v:
Transfusion. 51:2168-2174
Antibodies specific for the white blood cell antigen HNA-3a are particularly prone to cause severe, often fatal transfusion-related acute lung injury (TRALI),1–3 but it has not been possible to screen blood donors routinely for anti-HNA-3a because